|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.48 USD | +2.51% |
|
+9.97% | +26.61% |
| 06-10 | CVS Will Pay $36.5 Million to Settle Insulin Fraud Claims With State AGs, DOJ | DJ |
| 06-08 | UBS Adjusts Price Target on CVS Health to $115 From $100, Maintains Buy Rating | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 125B | BB | ||||||||
| 82.82B | - | BBB | - | - | |||||
| 24.53B | BBB | ||||||||
| 22.56B | AA | ||||||||
| 20.01B | A | ||||||||
| 14.19B | BB | ||||||||
| 13.82B | BBB | ||||||||
| 12.75B | - | AA | - | - | |||||
| 12.05B | BBB | ||||||||
| 10.32B | BBB | ||||||||
| 8.77B | CCC | ||||||||
| 7.95B | - | - | - | - | - | - | |||
| 5.74B | - | A | - | - | |||||
| 5.43B | B | ||||||||
| 4.64B | A | ||||||||
| 4.25B | A | ||||||||
| 3.43B | BB | ||||||||
| 3.41B | BBB | ||||||||
| 3.36B | AAA | ||||||||
| 3.21B | BB | ||||||||
| Average | 19.41B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- CVS Stock
- Sector CVS Health Corporation
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















